CrushSCI.com
Journal Selection & Manuscript Polishing Services
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Elsevier SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
145.3Average days
139Median days
31Fastest days
226Longest days
1,6072025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

179 days

PRACTALL 2025: Artificial intelligence—application of allergy and immunology to patient care

AuthorsMohamed M. Shamji; Nicholas L. Rider; Ian Adcock; Thanai Pongdee; Stefano Del Giacco; Christopher Chang; Maria Jose Torres Jaén; Paul V. Williams

AffiliationsNational Heart and Lung Institute, Imperial College London, London, United Kingdom; NIHR Imperial Biomedical Research Centre, London, United Kingdom; Frankland and Kay Allergy Centre, Imperial College London, London, United Kingdom; Department of Health Systems and Implementation Science, Virginia Tech Carilion School of Medicine, Roanoke, Va; Section of Allergy and Immunology, Department of Pediatrics, The Carilion Clinic, Roanoke, Va; Division of Allergic Diseases, Mayo Clinic, Rochester, Minn; Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy; Division of Immunology, Allergy and Pediatric Rhematology, Memorial Healthcare System, Joe DiMaggio Children’s Hospital, Hollywood, Fla; Instituto de Investigación Biomédica de Málaga (IBIMA-Plataforma BIONAND), Málaga, Spain; Department of Environmental Health, University of Washington, Seattle, Wash; Department of Pediatrics, University of Washington, Seattle, Wash

Source PDF DOI Publisher page
177 days

Dupilumab outcomes in pediatric asthma by early eosinophil status: Post hoc analysis of VOYAGE/EXCURSION

AuthorsSharon Dell; Theresa W. Guilbert; Antoine Deschildre; Wanda Phipatanakul; Nikolaos G. Papadopoulos; Clare S. Murray; Changming Xia; Andrew Moraco; Marissa Shams; Leonard B. Bacharier

AffiliationsPediatric Respiratory Medicine, BC Children’s Hospital, Vancouver, British Columbia, Canada; University of British Columbia, Vancouver, British Columbia, Canada; Cincinnati Children’s Hospital and University of Cincinnati, Cincinnati, Ohio; CHU Lille, Université de Lille, and Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, Lille, France; Department of Allergy and Immunology, Boston Children’s Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass; National and Kapodistrian University of Athens, Athens, Greece; University of Manchester, Manchester, United Kingdom; Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Regeneron Pharmaceuticals Inc, Tarrytown, NY; Sanofi, Cambridge, Mass; Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr. Children’s Hospital at Vanderbilt University Medical Center, Nashville, Tenn

Source PDF DOI Publisher page
31 days

Practice parameter for inborn errors of immunity: What is new in the 2025 update

AuthorsJavier Chinen; Catherine C. Horner; Jordan S. Orange

AffiliationsDivision of Immunology, Allergy and Retrovirology, Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Division of Allergy, Immunology and Pulmonology, Department of Pediatrics, Washington University, St Louis, Mo; Division of Allergy and Immunology, Department of Pediatrics, University of Pennsylvania, Philadelphia, Pa

Source PDF DOI Publisher page
226 days

Multicytokine-based transcriptome-wide association study for 7 inflammatory skin disorders identifies candidate causal genes in keratinocytes

AuthorsHaihan Zhang; Matthew T. Patrick; Mrinal K. Sarkar; Rachael Bogle; Qinmengge Li; Ranjitha Uppala; Bethany E. Perez White; Lynn Petukhova; Nick Dand; Philip E. Stuart; Angela M. Christiano; Michael A. Simpson; Jonathan N. Barker; Stephan Weidinger; Robert L. Modlin; Regina C. Betz; Dinesh Khanna; John Varga; J. Michelle Kahlenberg; Kevin He; James T. Elder; Xiang Zhou; Johann E. Gudjonsson; Lam C. Tsoi

AffiliationsDepartment of Biostatistics, University of Michigan, Ann Arbor, Mich; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Mich; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Ill; Department of Dermatology, Grossman School of Medicine, New York University, New York, New York; Department of Medical and Molecular Genetics, School of Basic & Medical Biosciences, King’s College London, London, United Kingdom; Department of Dermatology, Columbia University, New York, New York; St John’s Institute of Dermatology, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom; Department of Dermatology, University Hospital, Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany; Department of Internal Medicine, Division of Dermatology, University of California, Los Angeles, Calif; Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Mich; Taubman Medical Research Institute, University of Michigan Medical School, Ann Arbor, Mich; Ann Arbor Veterans Affairs Hospital, Ann Arbor, Mich; Department of Statistics and Data Science, Yale University, New Haven, Conn; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Mich

Source PDF DOI Publisher page
134 days

Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis: STEPIn mechanistic substudy results

AuthorsJohann E. Gudjonsson; Katharina Bier; Swann Gaulis; Lam C. Tsoi; Mathias Cardner; Mrinal K. Sarkar; Anthony Coon; Christopher Cole; Jaanika Kärner; Anita Fernandez; Thomas Peters; Liv Eidsmo; Lars Iversen; Piotr Jagiello; Enrico Ferrero; Frank Kolbinger; Felix Lohmann; Curdin Conrad

AffiliationsUniversity of Michigan, Ann Arbor, Mich; Novartis Biomedical Research, Basel, Switzerland; Novartis Pharma AG, Basel, Switzerland; Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Gastro/Hud/Reuma, Karolinska University Hospital, Stockholm, Sweden; Aarhus University, Aarhus, Denmark; Department of Dermatology, Lausanne University Hospital CHUV and University of Lausanne, Lausanne, Switzerland

Source PDF DOI Publisher page
139 days

One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study

AuthorsKeiko Kan-o; Hiroko Watanabe; Kenji Chibana; Maho Suzukawa; Akihiko Tanaka; Katsunori Masaki; Shin Ohta; Hiroki Kabata; Koichiro Asano; Reiko Ito; Hiromasa Inoue; Takako Nakano; Hideki Kanda; Takafumi Yamashita; Yasushi Obase; Konomi Kobayashi; Naoya Sugimoto; Yoko Ito; Hiroaki Ogata; Koichi Takagi; Nobuharu Ohshima; Takashi Kinoshita; Hiroki Tashiro; Koichiro Takahashi; Keiji Oishi; Tsunahiko Hirano; Hideki Sakakibara; Konomi Sennari; Yukihiro Sugimoto; Takayuki Shiroyama; Susumu Fukahori; Tsuyoshi Oguma; Katsuyoshi Tomomatsu; Sho Shimada; Mitsuko Kondo; Tomohiro Akaba; Michihiro Yoshimi; Yuki Moriuchi; Mari Ujike; Miho Mitsui; Kaoruko Shimizu; Yuichiro Shindo; Seiko Takasawa; Keiko Wakahara; Tomoki Uno; Jun Miyata; Akane Ishida; Mayoko Tsuji; Akikazu Shimada; Isamu Okamoto

AffiliationsDepartment of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Respiratory Medicine, Tokyo Women’s Medical University, Tokyo, Japan; Department of Statistics and Data Center, Clinical Research Support Center Kyushu, Fukuoka, Japan; Department of Pulmonary Medicine, National Hospital Organization Okinawa Hospital, Okinawa, Japan; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan; Department of Medicine, Division of Respiratory Medicine and Allergology, Showa Medical University School of Medicine, Tokyo, Japan; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan; Division of Respiratory Medicine, Nihon University School of Medicine, Tokyo, Japan; Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan; Department of Respiratory Medicine, National Hospital Organization Fukuokahigashi Medical Center, Fukuoka, Japan; Department of Respiratory Medicine, University of Occupational and Environmental Health, Fukuoka, Japan; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan; Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan; Department of Respiratory Medicine, NHO Fukuoka National Hospital, Fukuoka, Japan; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University Hospital, Saga, Japan; Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan; Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, Japan; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan; Department of Respiratory Medicine, Institute of Science Tokyo Hospital, Tokyo, Japan; Infectious Diseases Treatment and Prevention Center, Department of Infectious Diseases, Nagasaki University Hospital, Nagasaki, Japan; Department of Respiratory Medicine, University of Fukui Hospital, Fukui, Japan; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Hokkaido, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Aichi, Japan; Department of Respiratory Medicine, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan

Source PDF DOI Publisher page
124 days

Circulating extracellular vesicles drive innate immune dysregulation in MIS-C

AuthorsTugce Canavar Yildirim; Yasemin Ozsurekci; Muzaffer Yildirim; Volkan Yazar; Irem Evcili; Bilgi Gungor; Ismail Cem Yilmaz; Seza Ozen; Kubra Aykac; Ali Bulent Cengiz; Ulku Guler; Bekir Salih; Mayda Gursel; Ihsan Gursel

AffiliationsVaccine Development Research Program, Dokuz Eylul University, Izmir Biomedicine and Genome Center, Izmir, Turkiye; Molecular Biology and Genetics Department, Bilkent University, Ankara, Turkiye; Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkiye; Department of Genomics and Molecular Biotechnology, Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkiye; Department of Pediatric Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye; Department of Chemistry, Hacettepe University, Ankara, Turkiye

Source PDF DOI Publisher page
219 days

Homozygous loss-of-function mutation in SIT1 leads to combined immunodeficiency due to dysregulated T-cell receptor signaling

AuthorsPu Chen; Kim My Le; Weiwei Li; Francisca Hinrichsen; Xiaonan Liu; Ragnhild Selvig Braathen; Nanni Mamia; Monika Szymanska; Zhuokun Li; Luca Trotta; Henrikki Almusa; Katariina Mamia; Virpi Glumoff; Peter Holland; Simon Anders; Artem Kalinichenko; Meri Kaustio; Mikko R.J. Seppänen; Emma Maria Haapaniemi; Markku Varjosalo; Timi Martelius; Juha Grönholm; Janna Saarela

AffiliationsNorwegian Centre for Molecular Biosciences and Medicine (NCMBM), University of Oslo, Oslo, Norway; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland; Pediatric Research Center, New Children’s Hospital, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland; Institute of Biotechnology, University of Helsinki, Helsinki, Finland; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway; Department of Pediatrics, Oslo University Hospital, Oslo, Norway; Medical Research Laboratory Unit, Faculty of Medicine, University of Oulu, Oulu, Norway; Bioquant Center, University of Heidelberg, Heidelberg, Germany; Division of Immunology, Otto Loewi Research Center, Graz, Austria; Research Unit for Cancer and Inborn Errors of the Blood and Immunity in Children, Division of Pediatric Hematology-Oncology, Department of Pediatric and Adolescent Medicine, Medical University of Graz, Graz, Austria; Rare Diseases Center, New Children’s Hospital, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland; Adult Immunodeficiency Unit, Inflammation Center/Infectious Diseases, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland; Division of Hematology, Oncology, and Stem Cell Transplantation, New Children’s Hospital, HUS Helsinki University Hospital, Helsinki, Finland; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway

Source PDF DOI Publisher page
139 days

HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions

AuthorsChuang-Wei Wang; Wei-Ti Chen; Chun-Bing Chen; Chia-Yu Chu; Rosaline Chung-Yee Hui; Chun-Wei Lu; Tsu-Man Chiu; Shuen-Iu Hung; Huang Yu Huei; Wichittra Tassaneeyakul; Siew-Eng Choon; Nontaya Nakkam; Chonlaphat Sukasem; Yeong-Jian Jan Wu; Hsin-Yu Chung; Jr-Hau Lung; Jeng-Shou Chang; Yun-Shien Lee; Ya-Ching Chang; Kuang-Hui Yu; Yu-Chuan Teng; Shang-Hung Lin; Kuo-Chu Lai; Hsin-Han Hou; Jennifer Wu; Min-Hui Chi; Hua-En Lee; Yang Yu-Wei Lin; Yu-Jr Lin; Wen-Hung Chung

AffiliationsDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, and Keelung, Taiwan; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taiwan; Chang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China; Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital, Linkou, Taiwan; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan; hole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan; School of Medicine, National Tsing Hua University, Hsinchu, Taiwan; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Hospital Sultanah Aminah, Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Johor Bahru, Malaysia; Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand; The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) research group; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan; Department of Medical Research and Development, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan; Department of Biotechnology, Ming Chuan University, Taoyuan, Taiwan; Division of Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan; Genomic Medicine Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taiwan; Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Division of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan; Graduate Institute of Oral Biology, College of Medicine, National Taiwan University, Taipei, Taiwan; Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; Research Services Center for Health Information, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Beijing Tsinghua Chang Gung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Source PDF DOI Publisher page
85 days

Associations of rurality, child opportunity, and distance with use of pediatric asthma specialists

AuthorsJames Bohnhoff; Anya Cutler; Elizabeth A. Jacobs; Wanda Phipatanakul; Yvonne Jonk

AffiliationsDepartment of Pediatrics, MaineHealth, Portland, Me; Center for Interdisciplinary Population and Health Research, MaineHealth Institute for Research, Scarborough, Me; Department of Pediatrics, Tufts University School of Medicine, Boston, Mass; Department of Internal Medicine, University of California, Riverside, Riverside, Calif; Department of Immunology, Harvard Medical School, Boston, Mass; Muskie School of Public Health, University of Southern Maine, Portland, Me

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.